Teladoc (TDOC) Gets $7 Price Target: Can It Double?
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Learn which Dividend ETF Minimizes Capital Gains Retirement scenarios use to reduce tax exposure while keeping income stable. Simple steps to implement.
26,657 articlesBarclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
As investors scan the horizon for regenerative medicine players, Avita (RCEL) faces a pivotal quarter. This guide bre...
Palantir (PLTR) sits near $152 after a blowout Q1 2026. Investors weigh whether to buy, hold, or sell Palantir stock ...
Quantum tech is finally moving from labs to portfolios. This article breaks down why d-wave quantum shares soaring ha...
Two tech giants sit at the edge of a historic crown. This piece breaks down what would drive Apple about away from Nv...
A billionaire envoy sails a luxury superyacht along Italy’s coast, drawing protests in Venice and raising questions a...
Kalshi and Polymarket are reportedly exploring rounds that could push each platform toward $20 billion valuations, up...
3D Systems' Q1 2026 update sheds light on demand, margins, and cash flow across its printing systems, materials, and ...
Citigroup names Jenn Landis as CFO of its Markets unit, highlighting a broader leadership reshuffle aimed at aligning...
Analysts stage a fresh look at Tesla’s 2027 price target, signaling a measured path ahead as product rollouts and cas...
A notable stake from an experienced manager in a healthcare diagnostics stock signals a thoughtful, long term thesis....
Alphabet and Amazon are issuing investment-grade debt at scale, drawing funds away from U.S. Treasuries. The shift pl...